World of Bacteria header image

Escherichia coli – Beta-haemolytic Urinary Strain

A beta-haemolytic urinary isolate of Escherichia coli, demonstrating the considerable phenotypic diversity of this major uropathogen and the striking colony appearance that may accompany production of a haemolytic virulence factor.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Pseudomonadota (Proteobacteria)
  • Class: Gammaproteobacteria
  • Order: Enterobacterales
  • Family: Enterobacteriaceae
  • Genus: Escherichia
  • Species: Escherichia coli

Microscopy & Gram Stain

  • Gram-negative rods
  • Cells occur mainly singly, with pairs and short arrangements also possible
  • Abundant leukocytes may be visible in urine during active infection

Oxygen Relationship

  • Facultatively anaerobic

Rapid Identification Tests

  • Oxidase: negative
  • Catalase: positive
  • Indole: usually positive
  • Lactose fermentation: usually positive
  • Motility: usually positive
  • Haemolysis on blood agar: marked beta-haemolysis in this isolate

Ecology and Clinical Relevance

Natural Habitat

  • Human and animal intestinal tract
  • Common member of the normal colonic microbiota
  • May colonize the perineal and periurethral region before ascending into the urinary tract
  • Widely present in environments contaminated by faecal material

Common Clinical Specimens

  • Urine
  • Blood cultures
  • Wound and tissue specimens
  • Intra-abdominal material
  • Stool when intestinal pathogenic strains are suspected
  • Cerebrospinal fluid in neonatal infection

Clinical Significance

  • The most frequent bacterial cause of community-acquired urinary tract infection
  • Important cause of catheter-associated and healthcare-associated urinary infection
  • May cause cystitis, pyelonephritis, urosepsis, and bloodstream infection
  • Beta-haemolytic urinary isolates may produce alpha-haemolysin, a virulence factor present in a subset of uropathogenic strains

Differential Considerations

  • Klebsiella pneumoniae, Citrobacter, Enterobacter, and other lactose-fermenting Enterobacterales
  • Proteus mirabilis and other common urinary Gram-negative rods
  • Haemolytic Gram-negative isolates such as some Aeromonas species, which are typically oxidase positive
  • Colony appearance and beta-haemolysis are not species-specific and must be combined with biochemical or instrumental identification

Diagnostic and Clinical Notes

Escherichia coli is a highly diverse species. Most strains colonize the intestinal tract without causing disease, whereas specialized intestinal and extraintestinal lineages possess combinations of virulence factors that permit infection at other anatomical sites.

Uropathogenic E. coli is the leading bacterial cause of urinary tract infection. Infection usually develops by an ascending route after organisms from the intestinal microbiota colonize the periurethral region and enter the urinary tract.

The prominent beta-haemolysis seen in this isolate may reflect production of alpha-haemolysin (HlyA), an RTX-family pore-forming toxin found in a subset of uropathogenic E. coli. HlyA can injure epithelial and immune cells and may contribute to inflammation and tissue damage during urinary infection.

Visible haemolysis is a useful descriptive feature but is not sufficient to define a strain as uropathogenic or to determine its complete virulence profile. Haemolytic activity varies with the strain, culture conditions, toxin expression, and the presence of other haemolytic determinants.

In the original urine specimen, numerous Gram-negative rods were accompanied by abundant leukocytes. This combination supports an active inflammatory process, but the clinical significance still depends on quantitative culture, symptoms, specimen quality, and the patient’s overall condition.

Laboratory Identification

Colony Morphology

On blood agar after 18–24 hours at 35–37 °C, this isolate forms smooth, convex, grey-white colonies with entire margins and a broad zone of complete beta-haemolysis. Colony morphology among Escherichia coli strains is highly variable, and many urinary isolates are non-haemolytic. On lactose-containing differential media, most isolates ferment lactose and produce coloured colonies.

Microscopy

Gram staining shows Gram-negative rods, usually occurring singly. The original urine smear in this case contains numerous bacteria together with abundant leukocytes, supporting a substantial inflammatory response in the urinary tract.

Key Identification Clues

  • Gram-negative rods
  • Facultatively anaerobic growth
  • Oxidase negative
  • Catalase positive
  • Usually lactose fermenting
  • Usually indole positive and motile
  • Marked beta-haemolysis in this isolate, but haemolysis is variable within the species

Modern Identification Methods

Routine species identification is commonly achieved using MALDI-TOF mass spectrometry or automated biochemical systems. Molecular testing may be used when characterization of virulence genes such as hlyA, intestinal pathotypes, Shiga toxin production, resistance mechanisms, or epidemiologically important clones is required.

Antibiotic Characteristics

Antimicrobial susceptibility in Escherichia coli varies substantially between patients, geographical regions, clinical settings, and individual lineages.

Urinary isolates may be resistant to commonly used agents, including aminopenicillins, trimethoprim-sulfamethoxazole, and fluoroquinolones. Local resistance data are therefore important when empirical treatment is considered.

Extended-spectrum beta-lactamase production is an important resistance mechanism in both community and healthcare-associated isolates. Some strains also acquire carbapenemases or other mechanisms that further restrict treatment options.

Note: The beta-haemolytic appearance of this isolate does not predict its antimicrobial susceptibility. Treatment decisions should be guided by susceptibility testing, the site and severity of infection, and the clinical context.

External Resources

For broader general information about Escherichia coli, including taxonomy, ecology, and clinical importance, see: